Standout Papers

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in... 2003 2026 2010 2018 2.1k
  1. Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer (2003)
    Mark G. Kris, Ronald B. Natale et al. JAMA

Immediate Impact

2 by Nobel laureates 19 from Science/Nature 174 standout
Sub-graph 1 of 9

Citing Papers

Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
103 intermediate papers

Works of Judith Ochs being referenced

Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program
2006
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Judith Ochs 581 1947 343 1818 611 30 3.2k
Vaia Vlamis 329 1572 285 996 736 36 4.0k
Ben L. Sanford 634 1087 103 852 742 46 2.4k
Vincent Haddad 390 1321 75 1480 897 35 2.8k
C B Pratt 365 841 313 985 736 65 2.6k
Edward S. Baum 387 1180 325 540 890 42 2.5k
Robert B. Golbey 376 1856 117 1691 786 79 4.8k
Valerie Miké 240 727 253 859 297 40 2.4k
Helen Hickey 316 834 85 1909 298 44 3.3k
Allen M. Goorin 459 3321 61 2003 1123 56 6.1k
Richard B. Womer 350 3734 151 1533 1198 111 5.9k

All Works

Loading papers...

Rankless by CCL
2026